pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
the cabinet
Drugs
6,918
products tracked ·
1,486
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 2
APSA-02
Bacteremia
$ARMP
Armata Pharmaceuticals, Inc.
0
catalysts
Phase 2
APTA-16
Myelodysplastic Syndrome (Preleukemia)
AptaBio Therapeutics Inc
0
catalysts
Phase 2
ARCT-032
Cystic Fibrosis
$ARCT
Arcturus Therapeutics Holdings Inc.
0
catalysts
Phase 2
ARCT-165
← prev
page 5 of 50
next →
131
Pain
89
Neurology
1
Coronavirus Disease 2019 (COVID-19)
Seqirus Ltd
0
catalysts
Phase 2
ARCT-810
Ornithine-Transcarbamylase Deficiency
$ARCT
Arcturus Therapeutics Holdings Inc.
0
catalysts
Phase 2
ARD-103
Refractory Acute Myeloid Leukemia
ARCE Therapeutics Inc
0
catalysts
Phase 2
ART-6043
Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast…
Artios Pharma Ltd
0
catalysts
Phase 2
ARTHEx-01
Myotonic Dystrophy
ARTHEx Biotech SL
0
catalysts
Phase 2
ARTS-021
Endometrial Cancer
Avenzo Therapeutics Inc
0
catalysts
Phase 2
ARTS-023
Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast…
Avenzo Therapeutics Inc
0
catalysts
Phase 2
ARV-806
Colorectal Cancer
$ARVN
ARVINAS, INC.
0
catalysts
Phase 2
ASC-30
Obesity
Ascletis Pharma Inc
0
catalysts
Phase 2
ASC-618
Hemophilia A (Factor VIII Deficiency)
ASC Therapeutics Inc
0
catalysts
Phase 2
ASP-2957
X-Linked Myotubular Myopathy (XLMTM or MTM)
Astellas Pharma Inc
0
catalysts
Phase 2
ASP-7316
Juvenile Macular Degeneration (Stargardt Disease)
Astellas Pharma Inc
0
catalysts
Phase 2
ATA-200
Limb-Girdle Muscular Dystrophy
Atamyo Therapeutics SAS
0
catalysts
Phase 2
ATH-434
Multiple System Atrophy (Multi-System Degeneration)
$ATHE
ALTERITY THERAPEUTICS LTD
0
catalysts
Phase 2
ATR-04
Skin Rash
$AZTR
Azitra, Inc.
0
catalysts
Phase 2
ATRN-119
Ovarian Cancer
$APRE
Aprea Therapeutics, Inc.
0
catalysts
Phase 2
ATSN-101
Leber Congenital Amaurosis (LCA)
Atsena Therapeutics Inc
0
catalysts
Phase 2
ATX-295
Ovarian Cancer
Accent Therapeutics Inc
0
catalysts
Phase 2
AUTO-3
B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia)
$AUTL
Autolus Therapeutics plc
0
catalysts
Phase 2
AV-0328
Streptococcal Pneumonia
Alopexx Inc
0
catalysts
Phase 2
AV-1
Dengue Fever
Glutamate [NMDA] receptor
AbViro LLC
0
catalysts
Phase 2
AV-101
Major Depressive Disorder
Glutamate [NMDA] receptor
$VTGN
Vistagen Therapeutics, Inc.
0
catalysts
Phase 2
AVB-101
Frontotemporal Dementia (Pick Disease)
AviadoBio Ltd
0
catalysts
Phase 2
AVB-114
Anal Fistula
Avobis Bio LLC
0
catalysts
Phase 2
AVC-203
Diffuse Large B-Cell Lymphoma
AvenCell Therapeutics Inc
0
catalysts
Phase 2
AVGBM-1
Glioblastoma Multiforme (GBM)
AiVita Biomedical Inc
0
catalysts
Phase 2
AVRRD-04
Cystinosis
$NVS
NOVARTIS AG
0
catalysts
